Holley Introduces Fall Lineup to Kentucky Audience
Holley Performance Brands (NYSE: HLLY), a leader in automotive aftermarket performance solutions, today announced exciting new activations for its fall flagship event lineup, kicking off with the 16th annual LS Fest East, the largest and most recognized LS-powered celebration in the country. Held at Beech Bend Raceway in Bowling Green, Kentucky, LS Fest East draws enthusiasts from across the U.S. and around the globe for a weekend of high-octane motorsports, immersive brand experiences and community celebration.This year’s LS Fest East will feature two exciting additions that bring even more energy and variety to the lineup. Burnout Wars, an adrenaline-fueled showcase, brings together both professional and grassroots drivers in an entertaining burnout competition. With millions of engaged followers on social media, Burnout Wars influencers will create scroll-stopping content that helps expand Holley’s reach and visibility well beyond the live event. Ultra4 USA off-road racing, a premier off-road racing series recognized industry-wide, brings head-to-head truck competition on a professionally built dirt track, adding world-class motorsports prestige and attracting new fans and participants to LS Fest East.Said CEO Matthew Stevenson, “LS Fest East embodies our mission of bringing performance, fun and excitement to automotive enthusiasts. The event celebrates the LS enthusiast community and provides a platform for customer feedback and product innovation.” HLLY shares docked half a cent to $3.89.
Recent Posts

Romanian Inflation Ends Tumultuous Year in Politics Close to 10%

UK Boosts Support For Offshore Wind in Bumper Auction

Ireland Is Trying to Get Back on the Data Center Bandwagon

Notice Concerning Change of Representative Executive Officer

Polish Recycler Bets Millions on Europe’s Critical Metals Push

Blistering Metals Rally Sends Silver, Tin and Copper to Records

Wellington Management Appoints Alex Behm to Strengthen Secondaries Capabilities

TCS and AMD Announce Strategic Collaboration to Drive AI Adoption at Scale

New data reinforces Ipsen’s commitment to bringing solutions and addressing care gaps in neurological diseases at TOXINS

TOXINS 2026: Clinical Updates on Galderma’s Leading Neuromodulator Portfolio Further Reinforce Its Leadership in Injectable Aesthetics


